THIS IS YOUR LAST CHANCE TO ENTER! |
|
|
| |
Dear E,
This is your last chance to submit your groundbreaking innovations for the 2024 Fierce Healthcare Innovation Awards! These prestigious awards offer you a platform to elevate your innovation and connect with industry leaders.
Submissions close September 5th, and we want to see how your innovative solutions can shape the future of healthcare. |
|
|
| SUBMIT NOW | | | Why Submit? - Industry Recognition: Gain visibility and recognition from industry leaders, peers, and potential partners
- Credibility: Enhance your brand’s credibility and reputation by being associated with excellence and innovation
- Networking Opportunities: Connect with other innovators, key stakeholders, and decision-makers in the healthcare and life sciences sectors
- Media Exposure: Benefit from extensive media coverage, including features in Fierce Healthcare and Fierce Life Sciences publications
- Talent Attraction: Attract top talent by showcasing your commitment to innovation and excellence
- Motivation for Your Team: Celebrate your team’s hard work and achievements, boosting morale and motivation.
| | |
|
|
| |
We are thrilled to announce an additional submission category for the Fierce Healthcare Innovation Awards:
Artificial Intelligence Solutions
Recognizing groundbreaking advancements in the application of artificial intelligence within the healthcare sector. This category celebrates innovations that leverage AI technologies to significantly enhance patient outcomes, streamline healthcare processes, or advance medical research. |
|
|
| |
- Artificial Intelligence Solutions (New)
- Clinical Information Management
- Data Analytics/Business Intelligence
- Digital/Mobile Health Solutions
|
|
- Financial/Operational Solutions
- Population Health
- Management/Patient Engagement Solutions
|
|
|
| |
| |
2024 Key Dates & Information - Entry Fee: $575
- Submission Deadline: September 5
- Finalists Announced: October 22
- Winners Announced: November 27
Stay up-to-date and join our mailing list! |
|
|
| |
| |
| |
